Retinal anti-angiogenesis by a new route

Nature Biotechnology

Volumn 26, Issue 5, 2008, Pages 528-529

  Bicknell, Roy ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; HEALTH CARE; MEDICAL PROBLEMS;

RETINAL DISEASES; THERAPEUTIC POTENTIAL;

BIOELECTRIC PHENOMENA;

BEVACIZUMAB; EPHRIN RECEPTOR; NETRIN; ROUNDABOUT RECEPTOR; SLIT2 PROTEIN; VASCULOTROPIN;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; BRUCH MEMBRANE; CELL STRAIN; CELL STRAIN HEK293; CHOROID VASCULARIZATION; CRYSTAL STRUCTURE; DISEASE MODEL; HUMAN; IMMUNOPRECIPITATION; KNOCKOUT MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; RETINA MACULA AGE RELATED DEGENERATION; SHORT SURVEY; SUBRETINAL FLUID; THERAPY EFFECT; TREATMENT RESPONSE; X RAY ANALYSIS;

ANGIOGENESIS INHIBITORS; ANIMALS; DRUG DELIVERY SYSTEMS; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; RETINAL DISEASES; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 43449129723     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt0508-528     Document Type: Short Survey

References (10)

1. Jones, C.A. et al. Nat. Med. 14, 448-453 (2008).
2. Suchting, S., Bicknell, R. & Eichmann, A. Exp. Cell Res. 312, 668-675 (2006).
3. Huminiecki, L. et al. Genomics 79, 547-552 (2002).
4. Gerhardt, H. et al. J. Cell Biol. 161, 1163-1177 (2003).
5. Suchting, S. et al. FASEB J. 19, 121-123 (2005).
6. Hohenester, E., Hussain, S. & Howitt, J.A. Biochem. Soc. Trans. 34, 418-421 (2006).
7. Legg, J.A., Herbert, J.M., Clissold, P. & Bicknell, R. Angiogenesis 11, 13-21 (2008).
8. Wang, B. et al. Cancer Cell 4, 19-29 (2003).
9. Bedell, V.M. et al. Proc. Natl. Acad. Sci. USA 102, 6373-6378 (2005).
10. Kaur, S. et al. J. Biol. Chem. 281, 11347-11356 (2006).